147 related articles for article (PubMed ID: 31714163)
1. Development and characterization of exendin-4 loaded self-nanoemulsifying system and
Aktas Y; Celik Tekeli M; Celebi N
J Microencapsul; 2020 Jan; 37(1):41-51. PubMed ID: 31714163
[No Abstract] [Full Text] [Related]
2. Oral self-nanoemulsifying formulation of GLP-1 agonist peptide exendin-4: development, characterization and permeability assesment on Caco-2 cell monolayer.
Tekeli MC; Aktas Y; Celebi N
Amino Acids; 2021 Jan; 53(1):73-88. PubMed ID: 33398527
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the hypoglycemic effect of exendin-4's new oral self-nanoemulsifying system in rats.
Celik-Tekeli M; Celebi N; Tekeli MY; Aktas Y
Eur J Pharm Sci; 2021 Mar; 158():105644. PubMed ID: 33197556
[TBL] [Abstract][Full Text] [Related]
4. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
Gamal W; Fahmy RH; Mohamed MI
Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of lutein-loaded SNEDDS for enhanced absorption in Caco-2 cells.
Niamprem P; Rujivipat S; Tiyaboonchai W
Pharm Dev Technol; 2014 Sep; 19(6):735-42. PubMed ID: 23985012
[TBL] [Abstract][Full Text] [Related]
6. Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release.
Mahjub R; Dorkoosh FA; Rafiee-Tehrani M; Bernkop Schnürch A
J Microencapsul; 2015; 32(4):401-7. PubMed ID: 26052722
[TBL] [Abstract][Full Text] [Related]
7. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
8. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
[TBL] [Abstract][Full Text] [Related]
9. Quality by Design Approach for the Development of Self-Emulsifying Systems for Oral Delivery of Febuxostat: Pharmacokinetic and Pharmacodynamic Evaluation.
Rangaraj N; Shah S; A J M; Pailla SR; Cheruvu HS; D S; Sampathi S
AAPS PharmSciTech; 2019 Jul; 20(7):267. PubMed ID: 31346822
[TBL] [Abstract][Full Text] [Related]
10. Development and Characterization of a Self-Nanoemulsifying Drug Delivery System Comprised of Rice Bran Oil for Poorly Soluble Drugs.
Eleftheriadis GK; Mantelou P; Karavasili C; Chatzopoulou P; Katsantonis D; Irakli M; Mygdalia A; Vizirianakis IS; Fatouros DG
AAPS PharmSciTech; 2019 Jan; 20(2):78. PubMed ID: 30635752
[TBL] [Abstract][Full Text] [Related]
11. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
12. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation.
Qian J; Meng H; Xin L; Xia M; Shen H; Li G; Xie Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():101-109. PubMed ID: 28917148
[TBL] [Abstract][Full Text] [Related]
13. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
Miao Y; Chen G; Ren L; Pingkai O
Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
[TBL] [Abstract][Full Text] [Related]
14. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study.
Bandivadekar M; Pancholi S; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2013 May; 39(5):696-703. PubMed ID: 22616839
[TBL] [Abstract][Full Text] [Related]
15. Impact of various solid carriers and spray drying on pre/post compression properties of solid SNEDDS loaded with glimepiride: in vitro-ex vivo evaluation and cytotoxicity assessment.
Rajesh SY; Singh SK; Pandey NK; Sharma P; Bawa P; Kumar B; Gulati M; Jain SK; Gowthamarajan K; Singh S
Drug Dev Ind Pharm; 2018 Jul; 44(7):1056-1069. PubMed ID: 29360412
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.
Shen J; Bi J; Tian H; Jin Y; Wang Y; Yang X; Yang Z; Kou J; Li F
Int J Nanomedicine; 2016; 11():4919-4929. PubMed ID: 27713630
[TBL] [Abstract][Full Text] [Related]
17. Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation.
Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Lee BJ; Park YJ; Yong CS; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2017 Feb; 150():216-222. PubMed ID: 27918966
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system.
Zhang J; Li J; Ju Y; Fu Y; Gong T; Zhang Z
Mol Pharm; 2015 Feb; 12(2):504-13. PubMed ID: 25536306
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
20. Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient.
Patki M; Patel K
Drug Dev Ind Pharm; 2019 Mar; 45(3):405-414. PubMed ID: 30444435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
